Latest filing published 18 Feb 2026 for VERTEX PHARMACEUTICALS INC / MA, €112k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Sangeeta N. Bhatia is a declared insider of Vertex Pharmaceuticals INC / MA (board member), with filings sourced from SEC (Form 4). Over a trading history stretching from 1 June 2016 to 13 February 2026, the count stands at 56 filings.
Every open-market trade on record is a sale: 35 sales worth €8.6M. Besides market trades, the filings include 10 share grants and 11 option exercises. So far in 2026, the count stands at no purchases and 1 sale.
The newest entry dates from 18 February 2026: an open-market sale of €112k, in Vertex Pharmaceuticals INC / MA. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
18 of 18 declarations